Updated March 30 at 7:47pm

James Mazzo

James Mazzo has been appointed executive chairman at Neurotech Pharmaceuticals, where he will engage with the Neurotech team to advance the company’s technology platform toward market availability. More

To continue reading this article, please do one of the following.



Sign up to receive Providence Business News' newsletters
and breaking news alerts.  

BIOTECHNOLOGY

James Mazzo

Posted:

James Mazzo has been appointed executive chairman at Neurotech Pharmaceuticals, where he will engage with the Neurotech team to advance the company’s technology platform toward market availability. Mazzo was recently named chairman and CEO of AcuFocus, a Versant portfolio company. He holds a B.S. in zoology from California State University of Long Beach. •

082613Transitions, Issue 28~21, James Mazzo, Neurotech Pharmaceuticals, 28~21, 08262013Export.pbn

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment
Latest News